Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NeuBase Therapeutics, Inc. (O7PA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.1800-0.0070 (-3.74%)
At close: 08:00AM CET
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company

    PITTSBURGH, Oct. 21, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, today announced a research agreement with a Top 10 Global Healthcare company (“Healthcare Company”) (based on 2021 revenues). For this research, the Healthcare Company will evaluate NeuBase’s PATrOL™ technology for three monogenic genetic di

  • GlobeNewswire

    NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing

    Workforce reductions of ~60% and implementation of a robust cost reduction plan are expected to extend the Company’s cash runway into Q2 CY2024The Company plans to maximize shareholder value by focusing R&D resources on advancement of the differentiated gene editing capabilities of the Company’s platform Company to reduce activities and pursue partnerships for myotonic dystrophy type 1 (DM1), Huntington’s disease (HD), and KRAS (G12D & G12V) programsDov A. Goldstein, M.D., appointed Chairperson

  • GlobeNewswire

    NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference

    PITTSBURGH and CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, today announced that company management will participate in-person for a fireside chat at Chardan’s 6th Annual Genetic Medicines Conference being held in New York City on October 3-4, 2022. Details of the presentation a

Advertisement
Advertisement